External resources for tirzepatide and B12 research Clinical trial data for tirzepatide weight loss efficacy comes primarily from the SURMOUNT trial series published in The New England Journal of Medicine
Curcumin continues to calm inflammation post-infection
CJC-1295 without Drug Affinity Complex (NO DAC), also known as Modified GRF 1-29, is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of the first 29 amino acids with four strategic substitutions designed to enhance stability
Key Findings Obesity Worsens Sleep Apnea: For every 1-unit increase in BMI (e.g., going from a BMI of 30 to 31), patients experienced 1 additional breathing interruption per hour during sleep
In experiments involving mouse models exposed to CS, exposure to GHK-Cu was linked to a potential decrease in the production of pro-inflammatory cytokines, including interleukin-1 (IL-1) and tumor necrosis factor- (TNF-), found in bronchoalveolar lavage fluidfluid used to capture cells and soluble factors from the airways and lung tissues